Highbridge Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-3,100
Closed -$303K 1903
2015
Q1
$303K Buy
+3,100
New +$328K ﹤0.01% 1124
2014
Q3
Sell
-5,700
Closed -$597K 1535
2014
Q2
$597K Buy
+5,700
New +$485K 0.01% 697
2014
Q1
Sell
-4,600
Closed -$297K 1407
2013
Q4
$297K Buy
+4,600
New +$273K ﹤0.01% 846